Snakebite affects the lives of around 4.5 million people worldwide every year; seriously injuring 2.7 million men, women and children, and claiming some 125,000 lives.
Globally the greatest burden is experienced in the tropical world; where many nations remain under-developed or suffer from poor governance, political and/or social, conflict, resource scarcity, high disease burdens, or food insecurity. Remarkably snakebite is not a disease without a treatment, but sadly many hundreds of thousands of victims go untreated every year. Snake antivenoms, which were first developed in the 1890’s, offer the potential to save many, many lives, but high costs, poor availability, and in some cases, poor quality products produced by unscrupulous manufacturer’s have eroded confidence in antivenom immunotherapy, and many governments simply put the problem in the too-hard basket.
The Global Snakebite Initiative is an internationally-active non-profit organisation, registered in Australia, and led by snakebite experts who are dedicated to improving access to good quality, robustly tested, safe, effective antivenoms in the world’s poorest communities. We hope you will join us in trying to improve the prevention, first aid and treatment of snakebites, and in bringing recognition to the rehabilitation needs of snakebite victims around the world.
9 December 2016. GSI issues position statement on the steps needed to effectively control snakebite envenoming in Sub-Saharan African, and globally. Download the statement here.